Expertise in
10
conditions

Vidal Essebag

Montreal, QC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
Montreal, QC, CA 

Overview

Vidal Essebag practices practicing medicine in Montreal, Canada.

Mr. Essebag is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

He is actively involved in clinical research, co-authoring 175 peer reviewed articles and participating in 10 clinical trials.

Gender

Male

Locations

Montreal, QC, Canada
Other Locations
Canada
Quebec, QC H3G1A4, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's Hospital, Hamilton, ON, St. Michael's Hospital, Ottawa, ON, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's General Hospital, Victoria, Hamilton, ON, St. Michael's Hospital, Prince Albert, SK, Canada
Calgary, AB, Canada
Edmonton, AB, Canada
Vancouver, BC, Canada
Halifax, NS, Canada
Sherbrooke, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Cardiac Sarcoidosis Multi-Center Prospective Cohort Study
Cardiac Sarcoidosis Multi-Center Prospective Cohort Study
Enrollment Status: Recruiting
Publish Date: June 24, 2026
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
Enrollment Status: Completed
Publish Date: May 11, 2026
Intervention Type: Other, Procedure
Study Phase: Not Applicable
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Device
Study Phase: Not Applicable
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Ventricular Tachycardia Antiarrhythmics or AblatioN In Structural Heart Disease 2
Ventricular Tachycardia Antiarrhythmics or AblatioN In Structural Heart Disease 2
Enrollment Status: Completed
Publish Date: August 01, 2024
Intervention Type: Drug, Procedure
Study Drug: Antiarrythmic Drug Therapy
Study Phase: Phase 4
MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
Enrollment Status: Terminated
Publish Date: May 17, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Trial to Investigate Whether a Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at the Time of Device Surgery, in Patients With Moderate to High Risk of Arterial Thrombo-embolic Events, Leads to a Reduction in the Incidence of Clinically Significant Hematoma
A Randomized Controlled Trial to Investigate Whether a Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at the Time of Device Surgery, in Patients With Moderate to High Risk of Arterial Thrombo-embolic Events, Leads to a Reduction in the Incidence of Clinically Significant Hematoma
Enrollment Status: Completed
Publish Date: October 07, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

175 Total Publications

Contained pulmonary vein injury presenting as a hemorrhagic bulla post-pulsed field ablation: A case report.
Contained pulmonary vein injury presenting as a hemorrhagic bulla post-pulsed field ablation: A case report.
Journal: HeartRhythm case reports
Published: June 18, 2026

Frequently Asked Questions about Vidal Essebag

Is Vidal Essebag a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Vidal Essebag is classified as an Distinguished expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vidal Essebag participate in research or clinical trials?

Yes. Vidal Essebag has published 175 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Vidal Essebag's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Essebag's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile